How to drive payer submission readiness for your late-phase products

The PRMA Healthcheck® digital assessments of late-phase pharmaceutical assets help you to bring a clear understanding of the risks and opportunities in multiple markets based on current payer requirements.

This collection of case studies from leading pharmaceutical manufacturers explains how the PRMA Healthcheck® helps organizations to:

  • focus attention on the key issues that will impact outcomes of payer assessments

  • determine actions to mitigate the risks of not meeting payer expectations

  • identify clear responsibilities across global, regional, and affiliate teams for implementation of payer-focused activities

  • accelerate successful HTA submission and payer evaluation readiness by producing high-quality payer focused evidence that is driven by informed organizational collaboration.

FREE eBook

Drive readiness for payer submissions for your Phase 2 and 3 products

Free download

Latest insights

How to build an optimized GVD to ...

Fishawack Health Global Market Access

Fishawack Health expands its global market access ...

Navigating the US payer landscape and the ...